Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review
Authors:
Open Access
- 22 November 2025
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 14 (12) , 1393
Abstract
Nuclear factor erythroid 2-related factor 2 (NRF2) is a key transcription factor that controls the antioxidant response to oxidative stress, especially after exposure to ionizing radiation (IR). This review examines NRF2’s emerging role as a complementary biomarker in radiobiological dosimetry for assessing radiation exposure and its potential health effects. When cells encounter IR, the resulting reactive oxygen species (ROS) interfere with the NRF2 repressor KEAP1, leading to NRF2 activation and the expression of cytoprotective genes such as HO-1, NQO1, and GCLC. Evidence suggests that NRF2 levels increase in a dose- and time-dependent manner, primarily at low to moderate radiation doses, highlighting its potential for early detection of radiation exposure. However, at high doses (>8 Gy), NRF2 activation may be suppressed due to apoptosis or irreversible damage, which limits its reliability in those situations. The review also compares NRF2 with other biomarkers used in biodosimetry, discussing its advantages, such as sensitivity and early response, along with its limitations, including variability in activation at high doses and expression influenced by other oxidative factors. The authors introduce a comprehensive radiobiological model that illustrates how low-dose IR exposure affects NRF2 expression patterns, thereby improving the understanding of dose-dependent oxidative stress mechanisms. Additionally, the role of NRF2 in inflammation and general health risk assessment is emphasized, suggesting broader applications beyond biodosimetry. Overall, NRF2 holds significant promise for use in evaluating radiation exposure, developing radioprotection strategies, and informing future radiobiological research frameworks.Keywords
Funding Information
- University of Caen Normandy within the Young researcher program (SM2014-4016)
This publication has 114 references indexed in Scilit:
- NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the IcebergArchivos de Bronconeumología, 2024
- The effect of dietary phytochemicals on nuclear factor erythroid 2-related factor 2 (Nrf2) activation: a systematic review of human intervention trialsMolecular Biology Reports, 2021
- Eurados review of retrospective dosimetry techniques for internal exposures to ionising radiation and their applicationsRadiation and Environmental Biophysics, 2020
- Time‐Dependent Measurement of Nrf2‐Regulated Antioxidant Response to Ionizing Radiation Toward Identifying Potential Protein Biomarkers for Acute Radiation InjuryProteomics – Clinical Applications, 2019
- NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistanceJournal of Cancer Research and Clinical Oncology, 2019
- Low-Dose Irradiation Promotes Persistent Oxidative Stress and Decreases Self-Renewal in Hematopoietic Stem CellsCell Reports, 2017
- Mitochondrial DNA maintenance: an appraisalMolecular and Cellular Biochemistry, 2015
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and ProgressionCancer Cell, 2015
- Okadaic acid induces premature chromosome condensation reflecting the cell cycle progression in one‐cell stage mouse embryosMolecular Reproduction and Development, 1993
- A simple method for premature chromosome condensation induction in primary human and rodent cells using polyethylene glycolSomatic Cell and Molecular Genetics, 1983